SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-408602
Filing Date
2014-11-12
Accepted
2014-11-12 12:25:35
Documents
14
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d799343d10q.htm 10-Q 555539
2 EX-10.15 d799343dex1015.htm EX-10.15 68254
3 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER d799343dex311.htm EX-31.1 9642
4 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER d799343dex312.htm EX-31.2 9670
5 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER d799343dex321.htm EX-32.1 6584
12 GRAPHIC g799343ex10_15pg10a.jpg GRAPHIC 3336
13 GRAPHIC g799343ex10_15pg10b.jpg GRAPHIC 4392
14 GRAPHIC g799343ex10_15pg9.jpg GRAPHIC 4271
  Complete submission text file 0001193125-14-408602.txt   4071952

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aldx-20140930.xml EX-101.INS 449463
7 XBRL TAXONOMY EXTENSION SCHEMA aldx-20140930.xsd EX-101.SCH 44509
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20140930_cal.xml EX-101.CAL 50743
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20140930_def.xml EX-101.DEF 181045
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20140930_lab.xml EX-101.LAB 365165
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20140930_pre.xml EX-101.PRE 260804
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 141212679
SIC: 2834 Pharmaceutical Preparations